4.7 Article

Polysialic acid glycomimetics promote myelination and functional recovery after peripheral nerve injury in mice

期刊

BRAIN
卷 132, 期 -, 页码 1449-1462

出版社

OXFORD UNIV PRESS
DOI: 10.1093/brain/awp128

关键词

PSA mimetic; functional recovery; myelination; Schwann cells

资金

  1. Deutsche Forschungsgemeinschaft

向作者/读者索取更多资源

2,8 Polysialic acid (PSA) is a carbohydrate attached to the glycoprotein backbone of the neural cell adhesion molecule (NCAM) and implicated in nervous system development and repair. Here, we investigated whether PSA can improve functional recovery after peripheral nerve lesion in adult mice. We applied a functional PSA mimicking peptide or a control peptide in a polyethylene cuff used to surgically reconnect the severed stumps of the femoral nerve before it bifurcates into the motor and sensory branches. Using video-based motion analysis to monitor motor recovery over a 3 month postoperative period, we observed a better functional outcome in the PSA mimetic-treated than in control mice receiving a control peptide or phosphate buffered saline. Retrograde tracing of regenerated motoneurons and morphometric analyses showed that motoneuron survival, motoneuron soma size and axonal diameters were not affected by treatment with the PSA mimetic. However, remyelination of regenerated axons distal to the injury site was considerably improved by the PSA mimetic indicating that effects on Schwann cells in the denervated nerve may underlie the functional effects seen in motor recovery. In line with this notion was the observation that the PSA mimetic enhanced the elongation of Schwann cell processes and Schwann cell proliferation in vitro, when compared with the control peptide. Moreover, Schwann cell proliferation in vivo was enhanced in both motor and sensory branches of the femoral nerve by application of the PSA mimetic. These effects were likely mediated by NCAM through its interaction with the fibroblast growth factor receptor (FGFR), since they were not observed when the PSA mimetic was applied to NCAM-deficient Schwann cells, and since application of two different FGFR inhibitors reduced process elongation from Schwann cells in vitro. Our results indicate the potential of PSA mimetics as therapeutic agents promoting motor recovery and myelination after peripheral nerve injury.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Peripheral Vascular Disease

Intravascular Lithotripsy in Calcified Peripheral Lesions: Single-Center JEN-Experience

Pawel Aftanski, Marcus Thieme, Friederike Klein, P. Christian Schulze, Sven Moebius-Winkler, Daniel Kretzschmar

Summary: This single-center, prospective registry provides compelling evidence for the safety and efficacy of intravascular lithotripsy (IVL) in patients with severe peripheral artery disease (PAD) and calcified lesions. Clinical follow-up data showed a sustained improvement in ankle brachial index (ABI) after 6 months.

INTERNATIONAL JOURNAL OF ANGIOLOGY (2023)

Article Emergency Medicine

The use of andexanet alfa and 4-factor prothrombin complex concentrate in intracranial hemorrhage

Elly S. Oh, Paul Schulze, Frank Diaz, Kunal Shah, Jose Rios, Michael E. Silverman

Summary: This study compares the clinical and safety outcomes of andexanet alfa and 4-factor prothrombin complex concentrate for the reversal of apixaban or rivaroxaban-induced intracranial hemorrhage. The results show similar achievement of good hemostatic efficacy upon repeat CT scan between the two treatments, indicating that real-world outcomes align with clinical trial results.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2023)

Article Cardiac & Cardiovascular Systems

Intensive lipid-lowering therapy for early achievement of guideline-recommended LDL-cholesterol levels in patients with ST-elevation myocardial infarction (Jena auf Ziel)

Umidakhon Makhmudova, Beasat Samadifar, Aurel Maloku, Pellumb Haxhikadrija, Jens-Arndt Geiling, Robert Roemer, Bernward Lauer, Sven Moebius-Winkler, Sylvia Otto, P. Christian Schulze, Oliver Weingaertner

Summary: This study demonstrated that early combination therapy and progressive escalation of lipid-lowering treatment effectively achieved recommended LDL-C targets in patients with ST-elevation myocardial infarction, with minimal side effects.

CLINICAL RESEARCH IN CARDIOLOGY (2023)

Article Medicine, General & Internal

Targeted Interleukin-9 delivery in pulmonary hypertension: Comparison of immunocytokine formats and effector cell study

Judith Heiss, Katja Grun, Laura Tempel, Mattia Matasci, Andrea Schrepper, Michael Schwarzer, Reinhard Bauer, Martin Forster, Alexander Berndt, Christian Jung, P. Christian Schulze, Dario Neri, Marcus Franz

Summary: This study compared two formats of immunocytokines and identified potential target cells of IL9. The results showed that targeted delivery of IL9 could have beneficial effects in a mouse model of pulmonary hypertension (PH). Furthermore, IL9 treatment increased the number of regulatory T cells (Tregs) and reduced lung tissue damage in PH mice.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2023)

Article Cardiac & Cardiovascular Systems

Acute heart failure and cardiogenic shock An update

Julian G. Westphal, Paul Christian Schulze

Summary: Acute heart failure is a clinical syndrome characterized by elevated intracardiac filling pressures and systemic venous congestion. The underlying cardiac pathology and patient population are heterogeneous, leading to decreased perfusion and retrograde congestion. Therapeutic strategies aim to correct the cardiac dysfunction, reduce volume overload, and stabilize hemodynamics. However, empirical data from randomized trials in acute heart failure is less solid compared to chronic heart failure, resulting in a high mortality rate.
Article Biochemistry & Molecular Biology

The KDET Motif in the Intracellular Domain of the Cell Adhesion Molecule L1 Interacts with Several Nuclear, Cytoplasmic, and Mitochondrial Proteins Essential for Neuronal Functions

Ralf Kleene, Gabriele Loers, Melitta Schachner

Summary: Abnormal functions of L1 are associated with neural diseases. L1-55 fragment interacts with MeCP2, HP1, HistH1e, and other proteins via the KDET motif. These interactions regulate neurite outgrowth and neuronal survival, indicating the importance of L1 in neural system functions.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

The Interactions of the 70 kDa Fragment of Cell Adhesion Molecule L1 with Topoisomerase 1, Peroxisome Proliferator-Activated Receptor γ and NADH Dehydrogenase (Ubiquinone) Flavoprotein 2 Are Involved in Gene Expression and Neuronal L1-Dependent Functions

Gabriele Loers, Ralf Kleene, Ute Bork, Melitta Schachner

Summary: The L1 protein plays a crucial role in neural development, synaptic functions, and regeneration after trauma. L1-70 interacts with TOP1, PPAR gamma, and NDUFV2, and regulates neuronal growth and survival. The interaction of L1-70 with these proteins is also related to the expression of two essential autism genes and may be involved in both neurological and psychiatric dysfunctions.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Letter Cardiac & Cardiovascular Systems

Response by Schulze et al to Letter Regarding Article, Effects of Early Empagliflozin Initiation on Diuresis and Kidney Function in Patients With Acute Decompensated Heart Failure (EMPAG-HF)

P. Christian Schulze, Juergen Bogoviku, Julian Westphal, Pawel Aftanski, Franz Haertel, Sissy Grund, Stephan von Haehling, Ulrike Schumacher, Sven Moebius-Winkler, Martin Busch

CIRCULATION (2023)

Article Cardiac & Cardiovascular Systems

Cardiac Metabolism in Heart Failure and Implications for Uremic Cardiomyopathy

T. Dung Nguyen, P. Christian Schulze

Summary: Chronic kidney disease is associated with an increased risk of cardiovascular disorders and may cause structural remodeling and impairments in cardiac function. The concept of uremic cardiomyopathy, a specific cardiomyopathic phenotype, has recently been recognized. The metabolism in the myocardium of uremic heart shows overlapping mechanisms with heart failure. Understanding the similarities and differences in cardiac metabolism between heart failure and uremic cardiomyopathy could lead to new targets for research and treatment.

CIRCULATION RESEARCH (2023)

Editorial Material Medicine, General & Internal

51-year-old patient with recurrent pancreatitis and pathologic findings in plasma

Robert Roemer, P. Christian Schulze, Oliver Weingaertner

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2023)

Editorial Material Cardiac & Cardiovascular Systems

Great debate: in patients with decompensated heart failure, acetazolamide in addition to loop diuretics is the first choice

Wilfried Mullens, Paul Christian Schulze, Julian Westphal, Juergen Bogoviku, Johann Bauersachs

EUROPEAN HEART JOURNAL (2023)

Article Cardiac & Cardiovascular Systems

Use of mechanical circulatory support in patients with non-ischaemic cardiogenic shock

Benedikt Schrage, Jonas Sundermeyer, Benedikt Norbert Beer, Letizia Bertoldi, Alexander Bernhardt, Stefan Blankenberg, Jeroen Dauw, Zouhir Dindane, Dennis Eckner, Ingo Eitel, Tobias Graf, Patrick Horn, Paulus Kirchhof, Stefan Kluge, Axel Linke, Ulf Landmesser, Peter Luedike, Enzo Luesebrink, Norman Mangner, Octavian Maniuc, Sven Moebius Winkler, Peter Nordbeck, Martin Orban, Federico Pappalardo, Matthias Pauschinger, Michal Pazdernik, Alastair Proudfoot, Matthew Kelham, Tienush Rassaf, Hermann Reichenspurner, Clemens Scherer, Paul Christian Schulze, Robert H. G. Schwinger, Carsten Skurk, Marek Sramko, Guido Tavazzi, Holger Thiele, Luca Villanova, Nuccia Morici, Antonia Wechsler, Ralf Westenfeld, Ephraim Winzer, Dirk Westermann

Summary: This study aimed to evaluate the use of mechanical circulatory support (MCS) for the treatment of non-ischaemic cardiogenic shock (CS). The results showed that the use of MCS was associated with a lower 30-day mortality rate in patients with non-ischaemic CS. However, MCS treatment was also associated with more complications.

EUROPEAN JOURNAL OF HEART FAILURE (2023)

Article Biochemistry & Molecular Biology

X-ray structure and function of fibronectin domains two and three of the neural cell adhesion molecule L1

Gabriela Guedez, Gabriele Loers, Cy M. Jeffries, Sandra Kozak, Rob Meijers, Dmitri I. Svergun, Melitta Schachner, Christian Loew

Summary: The cell adhesion molecule L1 plays crucial roles in neural development, regeneration, synaptic plasticity, and tumor cell migration. L1 is a member of the immunoglobulin superfamily and consists of Ig-like domains and fibronectin type III homologous repeats. The second Ig-like domain is involved in cell binding, and the fibronectin type III homologous repeats contribute to signal transduction.

FASEB JOURNAL (2023)

Article Medicine, General & Internal

Effect of Hemolysis Regarding the Characterization and Prognostic Relevance of Neuron Specific Enolase (NSE) after Cardiopulmonary Resuscitation with Extracorporeal Circulation (eCPR)

Franz Haertel, Josephine Babst, Christiane Bruening, Jurgen Bogoviku, Sylvia Otto, Michael Fritzenwanger, Thomas Gecks, Henning Ebelt, Sven Moebius-Winkler, P. Christian Schulze, Ruediger Pfeifer

Summary: This study aimed to investigate the impact of hemolysis on neuron-specific enolase (NSE) levels and its prognostic value in predicting neurological outcomes in resuscitated patients without return of spontaneous circulation (ROSC) undergoing veno-arterial extracorporeal membrane oxygenation (VA-ECMO) therapy. The results showed that NSE is a reliable prognostic marker for poor neurological outcomes in resuscitated patients, and potential hemolysis during VA-ECMO does not significantly affect the prognostic value of NSE. These findings are crucial for clinical decision making and prognostic assessment in this patient population.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Medicine, General & Internal

Impact of a VA-ECMO in Combination with an Extracorporeal Cytokine Hemadsorption System in Critically Ill Patients with Cardiogenic Shock-Design and Rationale of the ECMOsorb Trial

Franz Haertel, Thomas Lehmann, Tabitha Heller, Michael Fritzenwanger, Ruediger Pfeifer, Daniel Kretzschmar, Sylvia Otto, Jurgen Bogoviku, Julian Westphal, Christiane Bruening, Thomas Gecks, Mirko Kaluza, Sven Moebius-Winkler, P. Christian Schulze

Summary: This article presents a clinical trial on the use of a cytokine adsorber to improve treatment outcomes in patients with cardiogenic shock. The study will compare the use of a cytokine adsorber with conventional plasma separation in treating cardiogenic shock patients. The primary endpoint of the study is improvement in cardiac function, with secondary outcomes including other clinical parameters and safety evaluation.

JOURNAL OF CLINICAL MEDICINE (2023)

暂无数据